Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Cell Therapy Asia 2018
Conferences  \  Cell Therapy Asia 2018  \  Agenda  \  Tatsuo Heki
RegisterLogin

Tatsuo Heki's Biography


Tatsuo Heki, Senior Expert, Regenerative Medicine Division, Fujifilm Corporation

Tatsuo Heki is Senior Expert at Fujifilm Regenerative Medicine Business Division. He is currently the chair of Japanese Mirror Committee for ISO/TC276 (Biotechnology). He is also leading the ISO/TC276/WG4 (Bioprocessing) at international level, which is working on the standardization in the field of regenerative medicine. He represents the Standardization Committee at FIRM (Forum for Innovative Regenerative Medicine), which is the primary industry organization promoting regenerative medicine in Japan. He has been working on standards since the days of Advanced Photographic System, which is the last photographic film system in its history. He received M.S. degree in synthetic chemistry from The University of Tokyo.

Tatsuo Heki Image

Industrialization of Regenerative Medicine - Standards are the Key

Thursday, 6 December 2018 at 11:00

Add to Calendar ▼2018-12-06 11:00:002018-12-06 12:00:00Europe/LondonIndustrialization of Regenerative Medicine - Standards are the KeyCell Therapy Asia 2018 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com

Industrialization of a particular field means making its product/service available anytime, anywhere and to anybody. Written standards in the field of regenerative medicine will form a common international “language” for use by the stakeholders including manufacturers, suppliers and regulators to support effective delivery of cell-based medicines, and is the centerpiece of industrialization.  ISO/TC 276 (International Organization for Standardization Technical Committee 276) Biotechnology. is developing standards in the areas of terms and conditions, biobanks and bioresources, analytical methods, bioprocessing and data processing in the field of biotechnology processes. ISO/TC 276 will contribute to regenerative medicine by establishing a common language for analytical methods and bioprocessing so that there is a more harmonized understanding by the stakeholders in the efforts from translation of research to transportation of cells for therapeutic use.

Add to Calendar ▼2018-12-06 00:00:002018-12-07 00:00:00Europe/LondonCell Therapy Asia 2018Cell Therapy Asia 2018 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors
Related Conferences
Organoids, Spheroids & Organs-on-Chips 2024
Location: Laguna Hills, California
Date: 18/11/2024 - 20/11/2024


Lab-on-a-Chip and Microfluidics World Congress 2024
Location: Laguna Hills, California
Date: 18/11/2024 - 20/11/2024


Innovations in Flow Cytometry & Extracellular Vesicles 2024
Location: Laguna Hills, California
Date: 18/11/2024 - 20/11/2024